Jacobio Pharmaceuticals Group (JBPHF) Short Interest Ratio & Short Volume

Short interest is the volume of Jacobio Pharmaceuticals Group shares that have been sold short but have not yet been closed out or covered. As of February 28th, investors have sold 303,900 shares of JBPHF short. Learn More on Jacobio Pharmaceuticals Group's current short interest.

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($23.74 billion), iShares 20+ Year Treasury Bond ETF ($10.75 billion), MicroStrategy Incorporated ($6.56 billion), Apollo Global Management, Inc. ($5.40 billion), Charter Communications, Inc. ($4.57 billion), AppLovin Co. ($4.45 billion), Capital One Financial Co. ($4.33 billion), Super Micro Computer, Inc. ($4.23 billion), Schlumberger Limited ($3.22 billion), and Royal Caribbean Cruises Ltd. ($3.06 billion). View all of the most shorted stocks.

Short selling JBPHF is an investing strategy that aims to generate trading profit from Jacobio Pharmaceuticals Group as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Jacobio Pharmaceuticals Group occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of JBPHF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including JBPHF, twice per month. The most recent reporting period available is February, 28 2025.